METOLAZONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metolazone, and when can generic versions of Metolazone launch?
Metolazone is a drug marketed by Alembic, Ani Pharms, Bayshore Pharms Llc, Innogenix, Leading, Mylan, Ne Rx Pharma, Renata, Roxane, Rubicon, Sandoz, and Watson Labs. and is included in thirteen NDAs.
The generic ingredient in METOLAZONE is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metolazone
A generic version of METOLAZONE was approved as metolazone by SANDOZ on December 19th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METOLAZONE?
- What are the global sales for METOLAZONE?
- What is Average Wholesale Price for METOLAZONE?
Summary for METOLAZONE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 13 |
| Finished Product Suppliers / Packagers: | 18 |
| Raw Ingredient (Bulk) Api Vendors: | 86 |
| Clinical Trials: | 23 |
| Patent Applications: | 4,017 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for METOLAZONE |
| What excipients (inactive ingredients) are in METOLAZONE? | METOLAZONE excipients list |
| DailyMed Link: | METOLAZONE at DailyMed |
See drug prices for METOLAZONE
Recent Clinical Trials for METOLAZONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Stadtspital Zürich | Phase 4 |
| Ospedale Regionale di Lugano | Phase 4 |
| Rambam Health Care Campus | Phase 4 |
Pharmacology for METOLAZONE
| Drug Class | Thiazide-like Diuretic |
| Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for METOLAZONE
Anatomical Therapeutic Chemical (ATC) Classes for METOLAZONE
US Patents and Regulatory Information for METOLAZONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | METOLAZONE | metolazone | TABLET;ORAL | 076891-001 | Jul 21, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rubicon | METOLAZONE | metolazone | TABLET;ORAL | 215184-003 | Aug 20, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | METOLAZONE | metolazone | TABLET;ORAL | 076732-001 | Dec 19, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic | METOLAZONE | metolazone | TABLET;ORAL | 213251-001 | Dec 2, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | METOLAZONE | metolazone | TABLET;ORAL | 076698-003 | Oct 19, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Renata | METOLAZONE | metolazone | TABLET;ORAL | 215616-003 | Oct 24, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bayshore Pharms Llc | METOLAZONE | metolazone | TABLET;ORAL | 214799-001 | Mar 30, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
